N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141031 |
| CAS No | NA |
| Mol.F. | C10H15N7OS |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141032 |
| CAS No | NA |
| Mol.F. | C22H27N5O7 |
| Mol.Wt. | 473.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141033 |
| CAS No | NA |
| Mol.F. | C22H24N8O10 |
| Mol.Wt. | 560.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141034 |
| CAS No | NA |
| Mol.F. | C22H25N7O9 |
| Mol.Wt. | 531.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141035 |
| CAS No | NA |
| Mol.F. | C22H26N6O8 |
| Mol.Wt. | 502.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141036 |
| CAS No | NA |
| Mol.F. | C22H27N5O7 |
| Mol.Wt. | 473.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141037 |
| CAS No | NA |
| Mol.F. | C22H26N6O8 |
| Mol.Wt. | 502.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141038 |
| CAS No | NA |
| Mol.F. | C7H16ClN4O6P |
| Mol.Wt. | 318.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141039 |
| CAS No | NA |
| Mol.F. | C7H17ClN3O5P : H2O |
| Mol.Wt. | 289.7 : 18.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141041 |
| CAS No | NA |
| Mol.F. | C4H9ClN2O2 |
| Mol.Wt. | 152.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141042 |
| CAS No | NA |
| Mol.F. | C7H17ClN3O5P |
| Mol.Wt. | 289.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141043 |
| CAS No | NA |
| Mol.F. | C7H14Cl2N3O3P : H2O |
| Mol.Wt. | 290.1 : 18.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141040 |
| CAS No | NA |
| Mol.F. | C7H15ClN3O4P |
| Mol.Wt. | 271.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141044 |
| CAS No | NA |
| Mol.F. | C28H48N14O6 |
| Mol.Wt. | 676.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141045 |
| CAS No | NA |
| Mol.F. | C28H53N9O |
| Mol.Wt. | 531.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141046 |
| CAS No | NA |
| Mol.F. | C28H53N9O : (C2H4O2) |
| Mol.Wt. | 531.8 : (60.1) |
| INV STATUS | CUSTOM SYNTHESIS |